Spire Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31K | Sell |
22
-13
| -37% | -$3.14K | ﹤0.01% | 1924 |
|
|
2025
Q1 | $8.53K | Sell |
35
-28
| -44% | -$6.82K | ﹤0.01% | 1885 |
|
|
2024
Q4 | $20.7K | Sell |
63
-2
| -3% | -$657 | ﹤0.01% | 1613 |
|
|
2024
Q3 | $21.7K | Buy |
65
+1
| +2% | +$335 | ﹤0.01% | 1415 |
|
|
2024
Q2 | $17.5K | Buy |
64
+55
| +611% | +$15K | ﹤0.01% | 1490 |
|
|
2024
Q1 | $3.11K | Sell |
9
-63
| -88% | -$21.8K | ﹤0.01% | 2019 |
|
|
2023
Q4 | $22.1K | Sell |
72
-3
| -4% | -$920 | ﹤0.01% | 1496 |
|
|
2023
Q3 | $26.9K | Buy |
75
+7
| +10% | +$2.51K | ﹤0.01% | 1391 |
|
|
2023
Q2 | $25.8K | Buy |
68
+24
| +55% | +$9.1K | ﹤0.01% | 1481 |
|
|
2023
Q1 | $21.1K | Buy |
44
+18
| +69% | +$8.62K | ﹤0.01% | 1594 |
|
|
2022
Q4 | $11K | Buy |
26
+18
| +225% | +$7.62K | ﹤0.01% | 1564 |
|
|
2022
Q3 | $3K | Hold |
8
| – | – | ﹤0.01% | 1845 |
|
|
2022
Q2 | $4K | Hold |
8
| – | – | ﹤0.01% | 2170 |
|
|
2022
Q1 | $5K | Sell |
8
-25
| -76% | -$15.6K | ﹤0.01% | 2220 |
|
|
2021
Q4 | $25K | Buy |
33
+25
| +313% | +$18.9K | ﹤0.01% | 2032 |
|
|
2021
Q3 | $6K | Hold |
8
| – | – | ﹤0.01% | 2223 |
|
|
2021
Q2 | $5K | Sell |
8
-6
| -43% | -$3.75K | ﹤0.01% | 2298 |
|
|
2021
Q1 | $8K | Buy |
+14
| New | +$8K | ﹤0.01% | 2466 |
|